9-Months and 12-Months Safety and Exploratory Efficacy Data of ANAVEX 2-73 in a Phase 2a Study

9th Clinical Trials on Alzheimer’s Disease (CTAD) 2016, San Diego, CA

Associate Professor Stephen Macfarlane, FRANZCP

View Presentation